In vitro evaluation of antiproliferative and cytotoxic properties of pterostilbene against human colon cancer cells

Acta Poloniae Pharmaceutica - Drug Research

Volumn 71, Issue 6, 2014, Pages 1051-1055

  Wawszczyk, Joanna ^a   Kapral, Małgorzata ^a   Hollek, Andrzej ^a   Węglarz, Ludmiła ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Caco 2 cell line; Colon cancer; Proliferation; Pterostilbene

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CYTOTOXIC AGENT; LACTATE DEHYDROGENASE; PTEROSTILBENE; STILBENE DERIVATIVE; SULFORHODAMINE B; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CACO 2 CELL LINE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; COLON CANCER; COMPARATIVE STUDY; CYTOTOXICITY; DRUG BIOAVAILABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; THERAPY EFFECT; CELL SURVIVAL; COLONIC NEOPLASMS; CULTURE TECHNIQUE; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; PATHOLOGY;

ANTICARCINOGENIC AGENTS; CACO-2 CELLS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; STILBENES;

EID: 84919918443     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wojciechowska U., Didkowska J., ZatoÒski W.: Cancer in Poland in 2008. National Cancer Registry of Poland, the Maria Sklodowska- Curie Memorial Cancer Center and Institute of Oncology, Warszawa 2010.
2. Rimando A.M., Suh N.: Planta Med. 74, 1635 (2008).
3. van Duijnhoven F.J., Bueno-De-Mesquita H.B., Ferrari P., Jenab M., Boshuizen H.C., Ros M.M., Casagrande C. et al.: Am. J. Clin. Nutr. 89, 1441 (2009).
4. Estrela J.M., Ortega A., Mena S., Rodriguez M.L., Asensi M.: Crit. Rev. Clin. Lab. Sci. 50, 65 (2013).
5. Remsberg C.M., Y•Òez J.A., Ohgami Y., Vega- Villa K.R., Rimando A.M., Davies N.M.: Phytother. Res. 22, 169 (2008).
6. Lin H.S., Yue B.D., Ho P.C.: Biomed. Chromatogr. 23, 1308 (2009).
7. Wang Y., Ding L., Wang X., Zhang J., Han W., Feng L., Sun J. et al.: Am. J. Transl. Res. 4, 44 (2012).
8. Chakraborty A., Gupta N., Ghosh K., Roy P.: Toxicol. In Vitro 24, 1215 (2010).
9. McCormack D., McFadden D.: J. Surg. Res. 173, 53 (2012).
10. Logan P., Burnier J., Burnier M.N.: Ecancermedicalscience 7, 336 (2013).
11. Haggar F.A., Boushey R.P.: Clin. Colon Rectal Surg. 22, 191 (2009).
12. Gingras D., BÈliveau R.: Cancer Microenviron. 4, 133 (2011).
13. Riche D., McEwen C., Riche K, Sherman J., Wofford M., Deschamp D., Griswold M.: J. Toxicol. 2013, 463595 (2013).
14. Paul S., DeCastro A.J., Lee H.J., Smolarek A.K., So J.Y., Simi B., Wang C.X. et al.: Carcinogenesis 31, 1272 (2010).
15. Chiou Y.S., Tsai M.L., Wang Y.J., Cheng A.C., Lai W.M., Badmaev V., Ho C.T., Pan M.H.: J. Agric. Food Chem. 58, 8833 (2010).
16. Hanahan D., Weinberg R.A.: Cell 100, 57 (2000).
17. Paul S., Rimando A.M., Lee H.J., Ji Y., Reddy B.S., Suh N.: Cancer Prev. Res. 2, 650 (2009).
18. Johnson J., Mukhtar H.: Cancer Lett. 255, 170 (2007).
19. Nutakul W., Sobers H.S., Qiu P., Dong P., Decker E.A., McClements D.J., Xiao H.: J. Agric. Food Chem. 59, 10964 (2011).
20. Harun Z., Ghazali A.R.: Asian Pac. J. Cancer Prev. 13, 6403 (2012).